Thus, in many cancers, T. gondii infection can modulate host immunosuppression to restrain tumor growth by upregulating the expression of interleukin-12 (IL-12) and interferon gamma (IFN-γ) [211]. This evidence concerns the gene IFNG and neoplasm.